Literature DB >> 24743143

Stargazing microRNA maps a new miR-21 star for cardiac hypertrophy.

Ciro Indolfi, Antonio Curcio.   

Abstract

Left ventricular hypertrophy is an initial compensatory mechanism in response to cardiac stress that can degenerate into heart failure and sudden cardiac death. Recent studies have shown that microRNAs (miRs) regulate several aspects of cardiovascular diseases. In this issue of the JCI, Bang and colleagues identified an exosome-mediated communication mechanism between cardiac fibroblasts and cardiomyocytes. Specifically, cardiac fibroblasts secrete miR-enriched exosomes, which are subsequently taken up by cardiomyocytes, in which they alter gene expression. In particular, a passenger strand miR, miR-21*, was identified as a potent paracrine factor that induces cardiomyocyte hypertrophy when shuttled through exosomes. These advanced comprehensive analyses represent a major step forward in our understanding of cardiovascular physiopathology, providing a promising adjunctive target for possible therapeutic approaches, namely the miR-mediated paracrine signaling network.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743143      PMCID: PMC4001563          DOI: 10.1172/JCI75801

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling.

Authors:  Paula A da Costa Martins; Meriem Bourajjaj; Monika Gladka; Mara Kortland; Ralph J van Oort; Yigal M Pinto; Jeffery D Molkentin; Leon J De Windt
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

2.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

3.  Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors:  Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal:  Science       Date:  2007-03-22       Impact factor: 47.728

4.  ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks.

Authors:  B Wang; E A Golemis; G D Kruh
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

5.  MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.

Authors:  Daniele Torella; Claudio Iaconetti; Daniele Catalucci; Georgina M Ellison; Angelo Leone; Cheryl D Waring; Angela Bochicchio; Carla Vicinanza; Iolanda Aquila; Antonio Curcio; Gianluigi Condorelli; Ciro Indolfi
Journal:  Circ Res       Date:  2011-08-18       Impact factor: 17.367

6.  Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation.

Authors:  Ciro Indolfi; Emilio Di Lorenzo; Cinzia Perrino; Angela Maria Stingone; Antonio Curcio; Daniele Torella; Antonello Cittadini; Luca Cardone; Carmela Coppola; Luigi Cavuto; Oreste Arcucci; Luigi Sacca; Enrico Vittorio Avvedimento; Massimo Chiariello
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

7.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.

Authors:  A W Haider; M G Larson; E J Benjamin; D Levy
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

8.  MicroRNA-133 controls cardiac hypertrophy.

Authors:  Alessandra Carè; Daniele Catalucci; Federica Felicetti; Désirée Bonci; Antonio Addario; Paolo Gallo; Marie-Louise Bang; Patrizia Segnalini; Yusu Gu; Nancy D Dalton; Leonardo Elia; Michael V G Latronico; Morten Høydal; Camillo Autore; Matteo A Russo; Gerald W Dorn; Oyvind Ellingsen; Pilar Ruiz-Lozano; Kirk L Peterson; Carlo M Croce; Cesare Peschle; Gianluigi Condorelli
Journal:  Nat Med       Date:  2007-04-29       Impact factor: 53.440

9.  Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.

Authors:  Adriana Osio; Lily Tan; Suet N Chen; Raffaella Lombardi; Sherif F Nagueh; Sanjay Shete; Robert Roberts; James T Willerson; Ali J Marian
Journal:  Circ Res       Date:  2007-03-08       Impact factor: 17.367

10.  Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.

Authors:  Claudia Bang; Sandor Batkai; Seema Dangwal; Shashi Kumar Gupta; Ariana Foinquinos; Angelika Holzmann; Annette Just; Janet Remke; Karina Zimmer; Andre Zeug; Evgeni Ponimaskin; Andreas Schmiedl; Xiaoke Yin; Manuel Mayr; Rashi Halder; Andre Fischer; Stefan Engelhardt; Yuanyuan Wei; Andreas Schober; Jan Fiedler; Thomas Thum
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

View more
  11 in total

Review 1.  Pathologic function and therapeutic potential of exosomes in cardiovascular disease.

Authors:  Shaina Ailawadi; Xiaohong Wang; Haitao Gu; Guo-Chang Fan
Journal:  Biochim Biophys Acta       Date:  2014-10-16

2.  Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.

Authors:  Changhai Tian; Guoku Hu; Lie Gao; Bryan T Hackfort; Irving H Zucker
Journal:  J Mol Cell Cardiol       Date:  2020-05-01       Impact factor: 5.000

3.  MicroRNA profiles in plasma samples from young metabolically healthy obese patients and miRNA-21 are associated with diastolic dysfunction via TGF-β1/Smad pathway.

Authors:  Pengkang Yang; Xin Dong; Yuyang Zhang
Journal:  J Clin Lab Anal       Date:  2020-02-28       Impact factor: 2.352

4.  Exosomes Derived from MicroRNA-146a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Alleviate Intracerebral Hemorrhage by Inhibiting Neuronal Apoptosis and Microglial M1 Polarization.

Authors:  Shurong Duan; Fei Wang; Jingwei Cao; Chunyan Wang
Journal:  Drug Des Devel Ther       Date:  2020-08-05       Impact factor: 4.162

5.  Construction of a microRNA‑associated feed‑forward loop network that identifies regulators of cardiac hypertrophy and acute myocardial infarction.

Authors:  Wenbo Qu; Shuai Shi; Lixiu Sun; Fan Zhang; Shengming Zhang; Shuainan Mu; Yanru Zhao; Bingchen Liu; Xue Cao
Journal:  Int J Mol Med       Date:  2018-07-20       Impact factor: 4.101

6.  Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge.

Authors:  Jaeyun Jung; Chanjoo Yeom; Yeon-Sook Choi; Sinae Kim; EunJi Lee; Min Ji Park; Sang Wook Kang; Sung Bae Kim; Suhwan Chang
Journal:  Oncotarget       Date:  2015-08-21

Review 7.  Extracellular Vesicles in Cardiovascular Theranostics.

Authors:  Yihua Bei; Saumya Das; Rodosthenis S Rodosthenous; Paul Holvoet; Maarten Vanhaverbeke; Marta Chagas Monteiro; Valter Vinicius Silva Monteiro; Jana Radosinska; Monika Bartekova; Felix Jansen; Qian Li; Johnson Rajasingh; Junjie Xiao
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556

8.  Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery.

Authors:  Sabato Sorrentino; Claudio Iaconetti; Salvatore De Rosa; Alberto Polimeni; Jolanda Sabatino; Clarice Gareri; Francesco Passafaro; Teresa Mancuso; Laura Tammè; Chiara Mignogna; Caterina Camastra; Giovanni Esposito; Antonio Curcio; Daniele Torella; Ciro Indolfi
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

Review 9.  Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging.

Authors:  Sherin Saheera; Prasanna Krishnamurthy
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 10.  Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease.

Authors:  Sergio Ayala-Mar; Belén Rodríguez-Morales; Pedro Chacón-Ponce; José González-Valdez
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.